BFRG: Bullfrog AI Projected Price to Earnings
Bullfrog AI Holdings (BFRG) accelerates drug discovery through biodata analysis, minimizing trial risks. Its cloud-based SaaS service ensures seamless infrastructure operation. High technological barriers are coupled with strict adherence to medical safety standards. The company's current forward P/E clearly demonstrates the valuation trend, while the value 0.00 captures the metric level on this chart.
Bullfrog AI Holdings Inc - analytical breakdowns and key metrics (BFRG)
- stock quotes and analyst forecast:
- market capitalization information:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Capital Bullfrog AI Holdings|BFRG - Long-Term Liabilities to Equity|Short-Term Debt to Equity Bullfrog AI Holdings|BFRG - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Bullfrog AI Holdings Inc|BFRG - Long-Term Debt|Company Short-Term Debts Bullfrog AI|Quick Liquidity Indicator bullfrogai.com
- company profitability and valuation multiples indicators:
BFRG - Final Profit|Projected Future Earnings Bullfrog AI Holdings|BFRG - P/E Multiple|Forward P/E Multiple Bullfrog AI Holdings|BFRG - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Bullfrog AI Holdings Inc|BFRG - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Bullfrog AI|BFRG - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months bullfrogai.com|BFRG - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Bullfrog AI Holdings
- issuer revenue and sales details:
Fundamental valuation:BFRG Bullfrog AI
Bullfrog AI Holdings (BFRG) is scaling AI implementation in pharmaceuticals to optimize drug development, making the assessment of future revenues critical. By analyzing the company's current forward P/E, an investor compares market value with projected annual earnings: low values signal an undervalued growth potential, while sharp drawdowns warn of risks regarding capital stagnation in this asset.
Competitors of Bullfrog AI Holdings (BFRG)
Forward P/E Multiple VEEV|Future Price to Earnings DOCS (Doximity Inc)|HealthEquity Corp - Projected Price to Earnings|Forward P/E Multiple Waystar Corp WAY|CRVL - Future Price to Earnings|PRVA: Future Price to Earnings|Huron (HURN) - Future Price to Earnings|CERT (Certara Inc) - Future Price to Earnings|OMCL (Omnicell Corp) - Forward P/E Multiple|GoodRx Gold - Price to Expected Earnings Ratio|Future Price to Earnings Schrodinger, Inc. (SDGR)|PHR (phreesia.com) - Future Price to Earnings Multiple|Future Price to Earnings Omada Health OMDA|Evolent Health Inc (EVH) - Projected Price to Earnings Ratio|HealthStream Corp - Forward P/E Multiple|Forward Price to Earnings Multiple Definitive Corp (DH)|CCSI (Consensus Cloud Solutions) - Projected Price to Earnings|agilonhealth.com - Future Price to Earnings Multiple|ABSI (Absci Corporation) - Forward P/E Multiple|Forward P/E Multiple So-Young International Inc|Forward P/E Multiple NRC|Market Cap to Projected Earnings USA Mobility|OptimizeRx Corporation - Projected Price to Earnings|Future Price to Earnings Multiple TBRG|Simulations Plus - Forward P/E Multiple|Future Price to Earnings Multiple SOPH (SOPHiA GENETICS SA)|Health Catalyst, Inc (HCAT) - Future Price to Earnings|Projected Price to Earnings Ratio CareCloud (CCLD)|Future Price to Earnings Research Solutions|Future Price to Earnings DLHC|Forward P/E Multiple ONMD|Scienture Holdings - Price to Future Earnings Ratio|Forward P/E Multiple HCTI (Healthcare Triangle Corp)|Market Cap to Projected Earnings iSpecimen Inc (ISPC)|WORX - Future Price to Earnings|MSPR (msprecovery.com) - Price to Future Earnings Ratio|ICCT: Forward P/E Multiple|Forward Price to Earnings Multiple TRxADE HEALTH Inc MEDS|Future Price to Earnings Orgenesis Corp|R1 RCM Inc (RCM) - Market Cap to Projected Earnings|Forward P/E Multiple SHCR|Future Price to Earnings STRM (streamlinehealth.net)|Forward P/E Multiple SYRA (Syra Health)|AMEH (Apollo Medical Holdings Inc.) - Price to Expected Earnings Ratio|MODN - Future Price to Earnings|Future Price to Earnings Multiple NXGN (NextGen Healthcare Corp)
